Admission Date:  [**2127-3-24**]              Discharge Date:   [**2127-3-31**]  Date of Birth:  [**2063-7-21**]             Sex:   F  Service: CARDIOTHORACIC  Allergies: Iodine  Attending:[**First Name3 (LF) 1505**] Chief Complaint: positive stress test  Major Surgical or Invasive Procedure: CABG X 3, PFO closure, MV repair (26 mm ring) on [**2127-3-24**]   History of Present Illness: 63 y/o w/known CAD, monitored by regular stress tests, most recently positive, referred for cardiac catheterization.
Past Medical History: CAD s/p LAD stenting hyperlipidemia DM Hodgkin's disease hypothyroidism GERD Barrett's esophagus s/p hemmorhoidectomy   Social History: divorced, lives alone works as a software trainer no ETOH or tobacco  Family History: non-contributory  Physical Exam: unremarkable pre-operatively  Pertinent Results: [**2127-3-31**] 06:40AM BLOOD WBC-12.9* RBC-2.79* Hgb-8.2* Hct-25.0* MCV-90 MCH-29.6 MCHC-32.9 RDW-16.8* Plt Ct-463* [**2127-3-31**] 06:40AM BLOOD Plt Ct-463* [**2127-3-30**] 05:55AM BLOOD PT-12.4 PTT-23.8 INR(PT)-1.1 [**2127-3-30**] 05:55AM BLOOD Glucose-141* UreaN-18 Creat-0.9 Na-140 K-4.9 Cl-104 HCO3-30 AnGap-11  PATIENT/TEST INFORMATION: Indication: Left ventricular function.
Height: (in) 64 Weight (lb): 210 BSA (m2): 2.00 m2 BP (mm Hg): 110/46 HR (bpm): 80 Status: Inpatient Date/Time: [**2127-3-28**] at 10:00 Test: Portable TTE (Complete) Doppler: Full Doppler and color Doppler Contrast: Definity Tape Number: 2007W000-0:00 Test Location: West SICU/CTIC/VICU Technical Quality: Suboptimal     REFERRING DOCTOR: DR. [**First Name (STitle) **] R. [**Doctor Last Name **]  MEASUREMENTS: Left Atrium - Long Axis Dimension: 3.5 cm (nl <= 4.0 cm) Left Ventricle - Septal Wall Thickness: 1.1 cm (nl 0.6 - 1.1 cm)  Left Ventricle - Inferolateral Thickness: *1.2 cm (nl 0.6 - 1.1 cm) Left Ventricle - Diastolic Dimension: 4.2 cm (nl <= 5.6 cm) Left Ventricle - Systolic Dimension: 2.6 cm Left Ventricle - Fractional Shortening: 0.38 (nl >= 0.29) Left Ventricle - Ejection Fraction: >= 55% (nl >=55%) Aorta - Valve Level: 3.2 cm (nl <= 3.6 cm) Aorta - Ascending: 3.2 cm (nl <= 3.4 cm) Aortic Valve - Peak Velocity: 1.9 m/sec (nl <= 2.0 m/sec) Mitral Valve - Peak Velocity: 1.4 m/sec Mitral Valve - Mean Gradient: 6 mm Hg Mitral Valve - Pressure Half Time: 115 ms Mitral Valve - E Wave: 1.4 m/sec Mitral Valve - A Wave: 1.2 m/sec Mitral Valve - E/A Ratio: 1.17 Mitral Valve - E Wave Deceleration Time: 407 msec TR Gradient (+ RA = PASP): 23 mm Hg (nl <= 25 mm Hg)  INTERPRETATION:  Findings:  This study was compared to the prior study of [**2127-3-13**].
Suboptimal image quality - bandages, defibrillator pads or electrodes.
Brief Hospital Course: Admitted to the pre-op holding area on [**2127-3-24**], taken to the OR, underwent CABG X 3, PFO closure, MV repair.
In the initial post-op period she required pressors and inotropes, she had a metabolic acidosis for which she received NaHCO3.
She was weaned from mechanical vantilation, and extubated on POD # 1.
On POD # 2, she was placed on IV ceftriaxone for positive gm stain of her sputum and elev.
Her pressors and inotropes were weaned off over the next few days.
Ms. [**Known lastname 28673**] did have some junctional rhythm while in the CSRU, and her beta blockers were initially held for this.
She has remained hemodynamically stable, and has progressed well with physical therapy.
Medications on Admission: metformin omeprazole levoxyl toprol XL lipitor insulin folic acid ASA niaspan   Discharge Medications: 1.
Metformin 500 mg Tablet Sig: Two (2) Tablet PO BID (2 times a day).
Omeprazole 20 mg Capsule, Delayed Release(E.C.)
Levothyroxine 75 mcg Tablet Sig: Two (2) Tablet PO DAILY (Daily).
Toprol XL 25 mg Tablet Sustained Release 24 hr Sig: One (1) Tablet Sustained Release 24 hr PO once a day.
Furosemide 20 mg Tablet Sig: One (1) Tablet PO Q12H (every 12 hours) for 7 days.
Potassium Chloride 20 mEq Packet Sig: One (1) Packet PO Q12H (every 12 hours) for 7 days.
Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day).
Aspirin 81 mg Tablet, Delayed Release (E.C.)
Insulin Lispro (Human) 100 unit/mL Solution Sig: as pre-op Units Subcutaneous twice a day: 22 U Q am, and 28 U Q pm as pre-op.
Oxycodone-Acetaminophen 5-325 mg Tablet Sig: 1-2 Tablets PO Q4H (every 4 hours) as needed for pain.
Atorvastatin 80 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Niaspan 500 mg Tablet Sustained Release Sig: One (1) Tablet Sustained Release PO at bedtime.
Folic Acid 1 mg Tablet Sig: One (1) Tablet PO once a day.
Disp:*30 Tablet(s)* Refills:*2*   Discharge Disposition: Home With Service  Facility: Caritas Home Care  Discharge Diagnosis: MR PFO CAD DM hyperlipidemia GERD Barrett's esophagus   Discharge Condition: good   Discharge Instructions: may shower, no bathing or swimming for 1 month no creams, lotions or powders to any incisions no lifting > 10# for 10 weeks  Followup Instructions: with Dr. [**Last Name (STitle) **] in [**1-4**] weeks with Dr. [**Last Name (STitle) 7047**] in [**1-4**] weeks with Dr. [**Last Name (STitle) **] in [**3-6**] weeks    Completed by:[**2127-3-31**
